---
figid: PMC11223907__APS2024-4862706.003
pmcid: PMC11223907
image_filename: PMC11223907__APS2024-4862706.003.jpg
figure_link: /pmc/articles/PMC11223907/figure/F3/
number: Figure 3
figure_title: Possible causes of variation in cyclophosphamide kinetics.
caption: 'Possible causes of variation in cyclophosphamide kinetics. (a) The different
  POR enzyme polymorphisms and expression levels that can affect the drug bioactivation.
  (b) Sequence of administration - cyclophosphamide administration after busulphan
  since several enzymes are involved in both drugs'' metabolic pathways. Bu: busulphan;
  Cy: cyclophosphamide; CYP: cytochrome P450; GST: glutathione S-transferase; POR:
  cytochrome P450 oxidoreductase; THT: tetrahydrothiophene'
article_title: Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and
  Its Effect on Bioactivation and Pharmacokinetics
citation: Ibrahim El-Serafi, et al. Adv Pharmacol Pharm Sci. 2024;2024(NA).
year: '2024'
pub_date: 2024--
epub_date: 2024-6-27
doi: 10.1155/2024/4862706
journal_title: Advances in Pharmacological and Pharmaceutical Sciences
journa_nlm_ta: Adv Pharmacol Pharm Sci
publisher_name: Wiley
keywords: []
---
